XBiotech Inc
Symbol: XBIT (NASDAQ)
2.75
▼ (-2.66%) -0.075
Company Description:
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.
Key Stats
- Today's Open: $2.84
- Today's High: $2.865
- Today's Low: $2.74
- Today's Volume: 28.24K
- Yesterday Close: $2.82
- Yesterday High: $2.8898
- Yesterday Low: $2.78
- Yesterday Volume: 72.52K
- Last Min Volume: 100
- Last Min High: $2.745
- Last Min Low: $2.745
- Last Min VWAP: $2.745
Company Profile
- Name: XBiotech Inc
- Website: http://www.xbiotech.com
- Listed Date: 2015-04-15
- Location: AUSTIN, TX
- Market Status: Active
- CIK Number: 0001626878
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $83.84M
- Round Lot: 100
- Outstanding Shares: 30.49M
- Asset Type: CS
RECENT FILINGS FOR XBIT
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-02 | 8-K | View |
| 2025-08-13 | 10-Q | View |
| 2025-07-07 | ARS | View |
| 2025-07-07 | DEF 14A | View |
| 2025-06-24 | 8-K | View |
| 2025-05-14 | 10-Q | View |
| 2025-04-29 | 10-K/A | View |
| 2025-04-07 | 8-K | View |
| 2025-04-01 | 8-K | View |
| 2025-03-19 | 4 | View |
| 2025-03-18 | 10-K | View |
| 2025-02-04 | 4 | View |
| 2025-01-27 | SCHEDULE 13G/A | View |
| 2025-01-27 | SCHEDULE 13G/A | View |
| 2024-12-31 | 8-K | View |
| 2024-11-13 | 10-Q | View |
| 2024-08-12 | 10-Q | View |
| 2024-06-21 | 4 | View |
| 2024-06-21 | 4 | View |
| 2024-06-21 | 4 | View |
Latest News on XBIT